In fact, HO-1 overexpression protects from antitumor activity of cisplatin both Hep-2 laryngeal squamous cells and HepG-2 hepatoma cells as well as MNK-4 gastric cancer cells and A549 lung cancer cells [80,81]. Here, HMOX1 is linked to hepatocellular carcinoma.